About us

Vitestro specializes in creating autonomous robotic phlebotomy devices, with their primary product being Aletta®. This device automates the blood collection process by integrating advanced imaging and artificial intelligence, aiming to improve precision and efficiency in diagnostic procedures. Aletta® is designed to perform blood draws with minimal human intervention, ensuring consistency and reducing the potential for errors. The company addresses challenges in manual phlebotomy, such as staffing shortages and variability in sample collection. By automating this process, Vitestro seeks to alleviate the burden on healthcare professionals, enhance patient comfort, and improve the reliability of diagnostic results. This innovation has the potential to transform patient care by providing a more consistent and efficient method for blood collection. Vitestro differentiates itself through its focus on autonomous technology and close collaboration with healthcare institutions. The company has conducted clinical trials to validate the safety and efficacy of Aletta®, demonstrating a high first-stick success rate. Additionally, Vitestro has secured significant funding and achieved CE marking for Aletta®, positioning itself as a leader in the field of robotic phlebotomy.